Post-operative Residual Voiding Volume Following Bulking and Vaginal Prolapse Surgery and Impact on In-hospital Stay
POUR
1 other identifier
interventional
84
1 country
1
Brief Summary
Post operative urinary retention is a commonly observed complication following women undergoing urogynecology surgery. The trial includes patients undergoing bulking and vaginal prolapse surgery, who are randomized in two postoperative groups prior to surgery in order to test two void regimes. One group includes a strict voiding regime, where patients are discharged when voiding volume is minimum 150 ml and residual volume is maximum 200 ml. Comparatively, the minimalistic voiding group discharge patients after one spontaneous voiding, independent of voiding volume and residual volume. The primary aim of this study is to evaluate time to discharge in two different voiding trials techniques (strict vs minimalistic) after anterior, posterior or vaginal vault prolapse surgery as well as bulking surgery. Secondly, to register the development of postoperative urinary tract infection, urine retention, gynecological pain and patients' calls to the gynecological ward after discharge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2023
CompletedFirst Posted
Study publicly available on registry
September 25, 2023
CompletedStudy Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedApril 4, 2024
April 1, 2024
1.9 years
September 18, 2023
April 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Residual urine
Residual urine after surgery
12 hours postoperatively
Study Arms (2)
group B
ACTIVE COMPARATORGroup B is the intervention group with minimalistic voiding trial. The patients in this group need to have one spontaneous voiding before discharge with the sensation of normal voiding, meaning there is no measurement of the voiding volume or residual volume.
Group A
NO INTERVENTIONGroup A is the control group and presents the current procedures with strict voiding trial. The bladder is scanned before voiding to determine the bladder volume, and the voiding volume is measured. If the voiding volume is \>150 ml and the residual volume is \<200 ml, the patient can be discharged. If no acceptable residual volume is reached, the patient will be instructed in intermittent catheterization
Interventions
Eligibility Criteria
You may qualify if:
- Women who undergo anterior, posterior or vaginal vault prolapse surgery or bulking surgery at the departments of obstetric and gynecology, OUH.
- Women who have the catheter removed at the operating room.
- Women \>18 years old.
You may not qualify if:
- Any surgery performed by due to malignancy
- Previous cancer in the pelvic area
- Previous radiation therapy in the pelvic area
- Previous surgery in the pelvic area
- Patients not understanding Danish
- Patients with mental or similar illness
- Patients with multiple sclerosis or diabetes type 1
- Patients with late KAD removal based on per operative assessment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Odense University Hospitallead
- University of Southern Denmarkcollaborator
Study Sites (1)
martin Rudnicki
Odense C, Odense, 4300, Denmark
Study Officials
- PRINCIPAL INVESTIGATOR
Martin Rudnicki
Odense Universitetshospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 18, 2023
First Posted
September 25, 2023
Study Start
November 1, 2023
Primary Completion
October 1, 2025
Study Completion
October 1, 2025
Last Updated
April 4, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
no plan